Insider · CIK 0001550395

ALTSHULER DAVID

Reports to the SEC for 1 company · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001550395

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-22	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Scientific Officer	AAward	+7,866 sh	—	—	31,149
2026-01-22	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Scientific Officer	AAward	+3,328 sh	—	—	34,477
2025-05-15	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−52 sh	$424.69	−$22.1K	23,281
2025-03-13	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−3,231 sh	$510.00	−$1.65M	23,281
2025-03-10	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−3,231 sh	$500.00	−$1.62M	26,512
2025-03-03	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−3,231 sh	$490.00	−$1.58M	29,743
2025-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−1,272 sh	$480.00	−$611K	32,974
2025-02-26	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−5,954 sh	$479.61	−$2.86M	34,246
2025-02-25	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−848 sh	$480.95	−$408K	40,200
2025-02-24	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−3,971 sh	$483.28	−$1.92M	41,048
2025-02-20	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−1,111 sh	$480.00	−$533K	45,019
2025-02-14	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−2,293 sh	$463.46	−$1.06M	46,130
2025-02-12	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Scientific Officer	AAward	+5,324 sh	—	—	48,423
2025-02-10	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−2,142 sh	$467.98	−$1M	43,099
2025-02-04	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Scientific Officer	AAward	+12.3K sh	—	—	38,127
2025-02-04	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Scientific Officer	AAward	+7,114 sh	—	—	45,241
2024-11-15	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−15 sh	$478.56	−$7,178.4	25,813
2024-05-15	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−54 sh	$430.93	−$23.3K	25,813
2024-02-26	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−4,239 sh	$425.70	−$1.8M	25,813
2024-02-23	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−3,970 sh	$431.79	−$1.71M	30,052
2024-02-21	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−3,002 sh	$421.77	−$1.27M	34,022
2024-02-20	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−2,812 sh	$420.58	−$1.18M	41,026
2024-02-20	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−4,002 sh	$420.79	−$1.68M	37,024
2024-02-16	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−3,750 sh	$424.01	−$1.59M	43,838
2024-02-12	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−3,145 sh	$420.24	−$1.32M	47,588
2024-02-09	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−2,099 sh	$422.74	−$887K	50,733
2024-02-07	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Scientific Officer	AAward	+7,114 sh	—	—	52,832
2024-02-06	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Scientific Officer	AAward	+5,814 sh	—	—	37,852
2024-02-06	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Scientific Officer	AAward	+7,866 sh	—	—	45,718
2023-11-15	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−19 sh	$369.92	−$7,028.48	32,038
2023-08-09	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−63 sh	$345.51	−$21.8K	32,038
2023-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−3,636 sh	$287.23	−$1.04M	32,640
2023-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−300 sh	$288.74	−$86.6K	32,340
2023-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−302 sh	$289.60	−$87.5K	32,038
2023-02-24	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−3,970 sh	$289.12	−$1.15M	36,276
2023-02-21	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−36 sh	$291.01	−$10.5K	44,212
2023-02-21	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−1,223 sh	$292.76	−$358K	42,989
2023-02-21	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−1,843 sh	$294.03	−$542K	41,146
2023-02-21	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−900 sh	$294.73	−$265K	40,246
2023-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−3,750 sh	$292.85	−$1.1M	44,248
2023-02-14	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−800 sh	$295.79	−$237K	53,596
2023-02-14	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−842 sh	$296.85	−$250K	52,754
2023-02-14	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−395 sh	$297.97	−$118K	52,359
2023-02-14	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−2,165 sh	$299.08	−$648K	50,194
2023-02-14	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−1,888 sh	$300.11	−$567K	48,306
2023-02-14	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−308 sh	$301.02	−$92.7K	47,998
2023-02-13	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−5,990 sh	$298.26	−$1.79M	59,194
2023-02-13	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−245 sh	$296.44	−$72.6K	58,949
2023-02-13	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−2,160 sh	$298.47	−$645K	56,789
2023-02-13	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Scientific Officer	SSale	−1,893 sh	$299.36	−$567K	54,896

Recent filings

Accepted (ET)
Jan 264
ALTSHULER DAVID0000875320-26-000010
SEC(opens sec.gov)
May 194
ALTSHULER DAVID0000875320-25-000201
SEC(opens sec.gov)
Mar 174
ALTSHULER DAVID0000875320-25-000152
SEC(opens sec.gov)
Mar 124
ALTSHULER DAVID0000875320-25-000144
SEC(opens sec.gov)
Mar 54
ALTSHULER DAVID0000875320-25-000139
SEC(opens sec.gov)
Feb 284
ALTSHULER DAVID0000875320-25-000120
SEC(opens sec.gov)
Feb 264
ALTSHULER DAVID0000875320-25-000101
SEC(opens sec.gov)
Feb 244
ALTSHULER DAVID0000875320-25-000099
SEC(opens sec.gov)
Feb 194
ALTSHULER DAVID0000875320-25-000077
SEC(opens sec.gov)
Feb 144
ALTSHULER DAVID0000875320-25-000055
SEC(opens sec.gov)
Feb 124
ALTSHULER DAVID0000875320-25-000031
SEC(opens sec.gov)
Feb 64
ALTSHULER DAVID0000875320-25-000005
SEC(opens sec.gov)
Nov 194
ALTSHULER DAVID0000875320-24-000229
SEC(opens sec.gov)
May 174
ALTSHULER DAVID0000875320-24-000150
SEC(opens sec.gov)
Feb 274
ALTSHULER DAVID0000875320-24-000095
SEC(opens sec.gov)

Companies

VERTEX PHARMACEUTICALS INC / MAEVP, Chief Scientific OfficerVRTX

Address

C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE

BOSTON, MA, 02210